Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1608

1.

Interobserver reproducibility of tumor uptake quantification with 89Zr-immuno-PET: a multicenter analysis.

Jauw YWS, Bensch F, Brouwers AH, Hoekstra OS, Zijlstra JM, Pieplenbosch S, Schröder CP, Zweegman S, van Dongen GAMS, Menke-van der Houven van Oordt CW, de Vries EGE, de Vet HCW, Boellaard R, Huisman MC.

Eur J Nucl Med Mol Imaging. 2019 Jun 17. doi: 10.1007/s00259-019-04377-6. [Epub ahead of print]

PMID:
31209514
2.

Interlesional Heterogeneity of Metastatic Neuroendocrine Tumors Based on 18F-DOPA PET/CT.

de Hosson LD, van der Loo-van der Schaaf AM, Boellaard R, van Snick JH, de Vries EGE, Brouwers AH, Walenkamp AME.

Clin Nucl Med. 2019 Jun 13. doi: 10.1097/RLU.0000000000002640. [Epub ahead of print]

PMID:
31205146
3.

The 2nd sialic acid-binding site of influenza A virus neuraminidase is an important determinant of the hemagglutinin-neuraminidase-receptor balance.

Du W, Guo H, Nijman VS, Doedt J, van der Vries E, van der Lee J, Li Z, Boons GJ, van Kuppeveld FJM, de Vries E, Matrosovich M, de Haan CAM.

PLoS Pathog. 2019 Jun 10;15(6):e1007860. doi: 10.1371/journal.ppat.1007860. [Epub ahead of print]

4.

Short-Term Double Layer Mesh Stent Patency for Emergent or Elective Carotid Artery Stenting.

de Vries EE, Vonken EJ, Kappelle LJ, Toorop RJ, de Borst GJ.

Stroke. 2019 Jun 10:STROKEAHA118024586. doi: 10.1161/STROKEAHA.118.024586. [Epub ahead of print]

PMID:
31177981
5.

Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma.

Verhoeff SR, van Es SC, Boon E, van Helden E, Angus L, Elias SG, Oosting SF, Aarntzen EH, Brouwers AH, Kwee TC, Heskamp S, Hoekstra OS, Verheul H, van der Veldt AAM, de Vries EGE, Boerman OC, van der Graaf WTA, Oyen WJG, van Herpen CML.

Eur J Nucl Med Mol Imaging. 2019 Jun 6. doi: 10.1007/s00259-019-04358-9. [Epub ahead of print]

PMID:
31172212
6.

A meta-analysis of the effect of stent design on clinical and radiologic outcomes of carotid artery stenting.

de Vries EE, Meershoek AJA, Vonken EJ, den Ruijter HM, van den Berg JC, de Borst GJ; ENDORSE Study Group.

J Vasc Surg. 2019 Jun;69(6):1952-1961.e1. doi: 10.1016/j.jvs.2018.11.017. Review.

PMID:
31159989
7.

Volumetric assessment of extracranial carotid artery aneurysms.

de Vries EE, van Laarhoven CJHCM, Kuijf HJ, Hazenberg CEVB, van Herwaarden JA, Viergever MA, de Borst GJ.

Sci Rep. 2019 May 30;9(1):8108. doi: 10.1038/s41598-019-44553-0.

8.

Long-term environmental modifications affect BDNF concentrations in rat hippocampus, but not in serum.

Giacobbo BL, de Freitas BS, Vedovelli K, Schlemmer LM, Pires VN, Antoniazzi V, Santos CSD, Paludo L, Borges JV, de Lima DB, Schröder N, de Vries EFJ, Bromberg E.

Behav Brain Res. 2019 May 21;372:111965. doi: 10.1016/j.bbr.2019.111965. [Epub ahead of print]

PMID:
31125621
9.

Attentional Weighting in the Face Processing Network: A Magnetic Response Image-guided Magnetoencephalography Study Using Multiple Cyclic Entrainments.

de Vries E, Baldauf D.

J Cogn Neurosci. 2019 May 21:1-16. doi: 10.1162/jocn_a_01428. [Epub ahead of print]

PMID:
31112470
10.

Vaginal herb use and Chlamydia trachomatis infection: cross-sectional study among women of various ethnic groups in Suriname.

Van der Helm JJ, Schim van der Loeff MF, de Vries E, van der Veer C, Grünberg AW, Mans D, de Vries HJC.

BMJ Open. 2019 May 16;9(5):e025417. doi: 10.1136/bmjopen-2018-025417.

11.

Consideration of breast cancer subtype in targeting the androgen receptor.

Venema CM, Bense RD, Steenbruggen TG, Nienhuis HH, Qiu SQ, van Kruchten M, Brown M, Tamimi RM, Hospers GAP, Schröder CP, Fehrmann RSN, de Vries EGE.

Pharmacol Ther. 2019 May 8. pii: S0163-7258(19)30079-8. doi: 10.1016/j.pharmthera.2019.05.005. [Epub ahead of print] Review.

12.

99mTc-HYNIC-IL-2 scintigraphy to detect acute rejection in lung transplantation patients: a proof-of-concept study.

Telenga ED, van der Bij W, de Vries EFJ, Verschuuren EAM, Timens W, Luurtsema G, Slart RHJA, Signore A, Glaudemans AWJM.

EJNMMI Res. 2019 May 10;9(1):41. doi: 10.1186/s13550-019-0511-z.

13.

A review of bispecific antibodies and antibody constructs in oncology and clinical challenges.

Suurs FV, Lub-de Hooge MN, de Vries EGE, de Groot DJA.

Pharmacol Ther. 2019 Apr 24. pii: S0163-7258(19)30069-5. doi: 10.1016/j.pharmthera.2019.04.006. [Epub ahead of print] Review.

14.

Shortages of inexpensive essential medicines.

Vyas M, de Vries EGE, Casali PG, Tabernero J.

Lancet Oncol. 2019 May;20(5):e224-e225. doi: 10.1016/S1470-2045(19)30248-7. Epub 2019 Apr 18. No abstract available.

PMID:
31006527
15.

Meta-analysis of the outcomes of treatment of internal carotid artery near occlusion.

Meershoek AJA, de Vries EE, Veen D, den Ruijter HM, de Borst GJ; NEON study group.

Br J Surg. 2019 May;106(6):665-671. doi: 10.1002/bjs.11159. Review.

PMID:
30973990
16.

MAPK pathway activity plays a key role in PD-L1 expression of lung adenocarcinoma cells.

Stutvoet TS, Kol A, de Vries EG, de Bruyn M, Fehrmann RS, Terwisscha van Scheltinga AG, de Jong S.

J Pathol. 2019 Apr 11. doi: 10.1002/path.5280. [Epub ahead of print]

PMID:
30972766
17.

Knowledge and use of biosimilars in oncology: a survey by the European Society for Medical Oncology.

Giuliani R, Tabernero J, Cardoso F, McGregor KH, Vyas M, de Vries EGE.

ESMO Open. 2019 Mar 6;4(2):e000460. doi: 10.1136/esmoopen-2018-000460. eCollection 2019.

18.

Letter to the Editor: When Expertly Applied, ESMO-MCBS and ASCO Net Health Benefit Scores Usually Agree.

Cherny NI, de Vries EGE, Schilsky RL.

J Natl Compr Canc Netw. 2019 Apr 1;17(4):xxi. doi: 10.6004/jnccn.2019.7293. No abstract available.

PMID:
30959465
19.

ESMO-MCBS: setting the record straight.

Cherny NI, Tabernero J, de Vries EGE.

Lancet Oncol. 2019 Apr;20(4):e192. doi: 10.1016/S1470-2045(19)30174-3. No abstract available.

PMID:
30942179
20.

Stagnation in Decreasing Gastric Cancer Incidence and Mortality in Quito: Time Trend Analysis, 1985-2013.

Tarupi W, de Vries E, Cueva P, Yépez J.

J Cancer Epidemiol. 2019 Feb 26;2019:1504894. doi: 10.1155/2019/1504894. eCollection 2019.

21.

Correction to: Imaging of Bronchial Pathology in Antibody Deficiency: Data from the European Chest CT Group.

Schütz K, Alecsandru D, Grimbacher B, Haddock J, Bruining A, Driessen G, de Vries E, van Hagen PM, Hartmann I, Fraioli F, Milito C, Mitrevski M, Quinti I, Serra G, Kelleher P, Loebinger M, Litzman J, Postranecka V, Thon V, Babar J, Condliffe AM, Exley A, Kumararatne D, Screaton N, Jones A, Bondioni MP, Lougaris V, Plebani A, Soresina A, Sirignano C, Spadaro G, Galal N, Gonzalez-Granado LI, Dettmer S, Stirling R, Chapel H, Lucas M, Patel S, Farber CM, Meyts I, Banerjee AK, Hackett S, Hurst JR, Warnatz K, Gathmann B, Weidemann J, Berthold D, Baumann U; Chest CT in Antibody Deficiency Group.

J Clin Immunol. 2019 Feb;39(2):225-227. doi: 10.1007/s10875-019-00609-4.

PMID:
30905051
22.

Challenges in investigating patients with isolated decreased serum IgM: The SIMcal study.

Janssen LMA, van Hout RWNM, de Vries E; SIMcal Consortium.

Scand J Immunol. 2019 Jun;89(6):e12763. doi: 10.1111/sji.12763. Epub 2019 Apr 25.

PMID:
30887554
23.

RECIST 1.1 for Response Evaluation Apply Not Only to Chemotherapy-Treated Patients But Also to Targeted Cancer Agents: A Pooled Database Analysis.

Litière S, Isaac G, De Vries EGE, Bogaerts J, Chen A, Dancey J, Ford R, Gwyther S, Hoekstra O, Huang E, Lin N, Liu Y, Mandrekar S, Schwartz LH, Shankar L, Therasse P, Seymour L; RECIST Working Group.

J Clin Oncol. 2019 May 1;37(13):1102-1110. doi: 10.1200/JCO.18.01100. Epub 2019 Mar 12.

PMID:
30860949
24.

Web-based personalised information and support for patients with a neuroendocrine tumour: randomised controlled trial.

de Hosson LD, Bouma G, Stelwagen J, van Essen H, de Bock GH, de Groot DJA, de Vries EGE, Walenkamp AME.

Orphanet J Rare Dis. 2019 Feb 28;14(1):60. doi: 10.1186/s13023-019-1035-3.

25.

8O89Zr-labeled anti-PD-L1 CX-072 PET imaging in human xenograft and syngeneic tumors.

Giesen D, Broer LN, Lub-De Hooge MN, Popova I, Howng B, Vasiljeva O, de Vries EGE, Pool M.

Ann Oncol. 2019 Feb 1;30(Supplement_1). pii: mdz029.001. doi: 10.1093/annonc/mdz029.001. No abstract available.

PMID:
30810205
26.

89Zr-labeled Bispecific T-cell Engager AMG 211 PET Shows AMG 211 Accumulation in CD3-rich Tissues and Clear, Heterogeneous Tumor Uptake.

Moek KL, Waaijer SJH, Kok IC, Suurs FV, Brouwers AH, Menke-van der Houven van Oordt CW, Wind TT, Gietema JA, Schröder CP, Mahesh SVK, Jorritsma-Smit A, Lub-de Hooge MN, Fehrmann RSN, de Groot DJA, de Vries EGE.

Clin Cancer Res. 2019 Jun 15;25(12):3517-3527. doi: 10.1158/1078-0432.CCR-18-2918. Epub 2019 Feb 11.

PMID:
30745297
27.

A large pooled analysis refines gene expression-based molecular subclasses in cutaneous melanoma.

Wind TT, Jalving M, de Haan JJ, de Vries EGE, van Vugt MATM, Reijngoud DJ, van Rijn RS, Haanen JBAG, Blank CU, Hospers GAP, Fehrmann RSN.

Oncoimmunology. 2019 Jan 3;8(3):1558664. doi: 10.1080/2162402X.2018.1558664. eCollection 2019.

28.

Comparative Assessment of Clinical Benefit Using the ESMO-Magnitude of Clinical Benefit Scale Version 1.1 and the ASCO Value Framework Net Health Benefit Score.

Cherny NI, de Vries EGE, Dafni U, Garrett-Mayer E, McKernin SE, Piccart M, Latino NJ, Douillard JY, Schnipper LE, Somerfield MR, Bogaerts J, Karlis D, Zygoura P, Vervita K, Pentheroudakis G, Tabernero J, Zielinski C, Wollins DS, Schilsky RL.

J Clin Oncol. 2019 Feb 1;37(4):336-349. doi: 10.1200/JCO.18.00729. Epub 2018 Dec 17.

PMID:
30707056
29.

Friction in the contact between skin and a soft counter material: Effects of hardness and surface finish.

Klaassen M, de Vries EG, Masen MA.

J Mech Behav Biomed Mater. 2019 Apr;92:137-143. doi: 10.1016/j.jmbbm.2019.01.006. Epub 2019 Jan 10.

PMID:
30685727
30.

Beneficial Effects of Whole Body Vibration on Brain Functions in Mice and Humans.

Boerema AS, Heesterbeek M, Boersma SA, Schoemaker R, de Vries EFJ, van Heuvelen MJG, Van der Zee EA.

Dose Response. 2018 Dec 4;16(4):1559325818811756. doi: 10.1177/1559325818811756. eCollection 2018 Oct-Dec.

31.

Imaging of Bronchial Pathology in Antibody Deficiency: Data from the European Chest CT Group.

Schütz K, Alecsandru D, Grimbacher B, Haddock J, Bruining A, Driessen G, de Vries E, van Hagen PM, Hartmann I, Fraioli F, Milito C, Mitrevski M, Quinti I, Serra G, Kelleher P, Loebinger M, Litzman J, Postranecka V, Thon V, Babar J, Condliffe AM, Exley A, Kumararatne D, Screaton N, Jones A, Bondioni MP, Lougaris V, Plebani A, Soresina A, Sirignano C, Spadaro G, Galal N, Gonzalez-Granado LI, Dettmer S, Stirling R, Chapel H, Lucas M, Patel S, Farber CM, Meyts I, Banerjee AK, Hackett S, Hurst JR, Warnatz K, Gathmann B, Baumann U; Chest CT in Antibody Deficiency Group.

J Clin Immunol. 2019 Jan;39(1):45-54. doi: 10.1007/s10875-018-0577-9. Epub 2018 Dec 13. Erratum in: J Clin Immunol. 2019 Feb;39(2):225-227.

PMID:
30547383
32.

Outcome of liver transplant patients with high urgent priority. Are we doing the right thing?

de Boer J, Braat A, Putter H, de Vries E, Strassburg CH, Máthé Z, van Hoek B, Braun F, van den Berg A, Mikulic D, Michielsen P, Trotovsek B, Zoller H, de Boer J, van Rosmalen M, Samuel U, Berlakovich G, Guba M; Eurotransplant Liver and Intestine Advisory Committee (ELIAC).

Transplantation. 2018 Nov 21. doi: 10.1097/TP.0000000000002526. [Epub ahead of print]

PMID:
30489481
33.

Integrating molecular nuclear imaging in clinical research to improve anticancer therapy.

de Vries EGE, Kist de Ruijter L, Lub-de Hooge MN, Dierckx RA, Elias SG, Oosting SF.

Nat Rev Clin Oncol. 2019 Apr;16(4):241-255. doi: 10.1038/s41571-018-0123-y. Review.

PMID:
30479378
34.

89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer.

Bensch F, van der Veen EL, Lub-de Hooge MN, Jorritsma-Smit A, Boellaard R, Kok IC, Oosting SF, Schröder CP, Hiltermann TJN, van der Wekken AJ, Groen HJM, Kwee TC, Elias SG, Gietema JA, Bohorquez SS, de Crespigny A, Williams SP, Mancao C, Brouwers AH, Fine BM, de Vries EGE.

Nat Med. 2018 Dec;24(12):1852-1858. doi: 10.1038/s41591-018-0255-8. Epub 2018 Nov 26.

PMID:
30478423
35.

Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative 18F-FDG PET/CT analysis.

de Heer EC, Brouwers AH, Boellaard R, Sluiter WJ, Diercks GFH, Hospers GAP, de Vries EGE, Jalving M.

EJNMMI Res. 2018 Nov 20;8(1):101. doi: 10.1186/s13550-018-0453-x.

36.

The burden of common variable immunodeficiency disorders: a retrospective analysis of the European Society for Immunodeficiency (ESID) registry data.

Odnoletkova I, Kindle G, Quinti I, Grimbacher B, Knerr V, Gathmann B, Ehl S, Mahlaoui N, Van Wilder P, Bogaerts K, de Vries E; Plasma Protein Therapeutics Association (PPTA) Taskforce.

Orphanet J Rare Dis. 2018 Nov 12;13(1):201. doi: 10.1186/s13023-018-0941-0.

37.

Droplet Imbibition into Paper Coating Layer: Pore-Network Modeling Simulation.

Yin X, Aslannejad H, de Vries ET, Raoof A, Hassanizadeh SM.

Transp Porous Media. 2018;125(2):239-258. doi: 10.1007/s11242-018-1116-0. Epub 2018 Jul 13.

38.

Mild Hypogammaglobulinemia Can Be a Serious Condition.

Janssen LMA, Bassett P, Macken T, van Esch J, Pruijt H, Knoops A, Sköld M, Parker A, de Vries J, de Vries E.

Front Immunol. 2018 Oct 15;9:2384. doi: 10.3389/fimmu.2018.02384. eCollection 2018.

39.

Comparability of semiautomatic tortuosity measurements in the carotid artery.

de Vries EE, Pourier VEC, van Laarhoven CJHCM, Vonken EJ, van Herwaarden JA, de Borst GJ.

Neuroradiology. 2019 Feb;61(2):147-153. doi: 10.1007/s00234-018-2112-3. Epub 2018 Oct 18.

40.

Development and validation of a tool to measure patient experience in chronic disease care.

Manga N, Harding R, De Sa A, Murie K, Namane MK, Raubenheimer PJ, Hellenberg DA, De Vries E.

Afr J Prim Health Care Fam Med. 2018 Sep 11;10(1):e1-e7. doi: 10.4102/phcfm.v10i1.1830.

41.

Molecular imaging to enlighten cancer immunotherapies and underlying involved processes.

van der Veen EL, Bensch F, Glaudemans AWJM, Lub-de Hooge MN, de Vries EGE.

Cancer Treat Rev. 2018 Nov;70:232-244. doi: 10.1016/j.ctrv.2018.09.007. Epub 2018 Sep 25. Review.

PMID:
30308466
42.

Quantitative proteomics analysis identifies MUC1 as an effect sensor of EGFR inhibition.

de Boer HR, Pool M, Joosten E, Everts M, Samplonius DF, Helfrich W, Groen HJM, van Cooten S, Fusetti F, Fehrmann RSN, de Vries EGE, van Vugt MATM.

Oncogene. 2019 Feb;38(9):1477-1488. doi: 10.1038/s41388-018-0522-7. Epub 2018 Oct 10.

PMID:
30305724
43.

Preparing for the incoming wave of biosimilars in oncology.

Wolff-Holz E, Garcia Burgos J, Giuliani R, Befrits G, de Munter J, Avedano L, Aitken M, Gonzalez-Quevedo R, Vyas M, de Vries EGE, Tabernero J.

ESMO Open. 2018 Sep 5;3(6):e000420. doi: 10.1136/esmoopen-2018-000420. eCollection 2018. Erratum in: ESMO Open. 2018 Oct 14;3(6):e000420corr1.

44.

European Academy of Cancer Sciences - position paper.

Adami HO, Berns A, Celis JE, de Vries E, Eggermont A, Harris A, Zur Hausen H, Pelicci PG, Ringborg U.

Mol Oncol. 2018 Nov;12(11):1829-1837. doi: 10.1002/1878-0261.12379. Epub 2018 Sep 21.

45.

Tumor-associated macrophages in breast cancer: Innocent bystander or important player?

Qiu SQ, Waaijer SJH, Zwager MC, de Vries EGE, van der Vegt B, Schröder CP.

Cancer Treat Rev. 2018 Nov;70:178-189. doi: 10.1016/j.ctrv.2018.08.010. Epub 2018 Aug 28. Review.

46.

Comparative biodistribution analysis across four different 89Zr-monoclonal antibody tracers-The first step towards an imaging warehouse.

Bensch F, Smeenk MM, van Es SC, de Jong JR, Schröder CP, Oosting SF, Lub-de Hooge MN, Menke-van der Houven van Oordt CW, Brouwers AH, Boellaard R, de Vries EGE.

Theranostics. 2018 Jul 30;8(16):4295-4304. doi: 10.7150/thno.26370. eCollection 2018.

47.

Androgen receptor expression inversely correlates with immune cell infiltration in human epidermal growth factor receptor 2-positive breast cancer.

van Rooijen JM, Qiu SQ, Timmer-Bosscha H, van der Vegt B, Boers JE, Schröder CP, de Vries EGE.

Eur J Cancer. 2018 Nov;103:52-60. doi: 10.1016/j.ejca.2018.08.001. Epub 2018 Sep 9.

PMID:
30208359
48.

Editor's Choice - Cerebral Hyperperfusion Syndrome After Carotid Artery Stenting: A Systematic Review and Meta-analysis.

Huibers AE, Westerink J, de Vries EE, Hoskam A, den Ruijter HM, Moll FL, de Borst GJ.

Eur J Vasc Endovasc Surg. 2018 Sep;56(3):322-333. doi: 10.1016/j.ejvs.2018.05.012. Epub 2018 Jun 29.

PMID:
30196814
49.

Considering the biology of late recurrences in selecting patients for extended endocrine therapy in breast cancer.

Bense RD, Qiu SQ, de Vries EGE, Schröder CP, Fehrmann RSN.

Cancer Treat Rev. 2018 Nov;70:118-126. doi: 10.1016/j.ctrv.2018.07.015. Epub 2018 Jul 26. Review.

50.

The Effect of Histidine-tryptophan-ketoglutarate Solution and University of Wisconsin Solution: An Analysis of the Eurotransplant Registry.

de Boer JD, Strelniece A, van Rosmalen M, de Vries E, Ysebaert D, Guba M, Braat AE, Samuel U.

Transplantation. 2018 Nov;102(11):1870-1877. doi: 10.1097/TP.0000000000002406.

PMID:
30130321

Supplemental Content

Loading ...
Support Center